Modeling Changes in CD4-positive T-Lymphocyte Counts after the Start of Highly Active Antiretroviral Therapy and the Relation with Risk of Opportunistic Infections The Aquitaine Cohort, 1996

Modeling Changes in CD4-positive T-Lymphocyte Counts after the Start of Highly Active Antiretroviral Therapy and the Relation with Risk of Opportunistic Infections The Aquitaine Cohort, 1996–1997

Published:2001-02-15 Issue:4 Volume:153 Page:386-393
ISSN:1476-6256
Container-title:American Journal of Epidemiology
language:en
Short-container-title:

Author:

Binquet C.,Chêne G.,Jacqmin-Gadda H.,Journot V.,Savès M.,Lacoste D.,Dabis F.

Publisher

Oxford University Press (OUP)

Subject

Epidemiology

Link

http://academic.oup.com/aje/article-pdf/153/4/386/

Reference41 articles.

1. Collier AC, Coombs RW, Schoenfeld DA, et al. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. N Engl J Med1996;334:1011–17.

2. Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimiter or less. N Engl J Med1997;337:725–33.

3. Gulick RM, Mellors JW, Havlir D, et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med1997;337:734–9.

4. Cameron DW, Heath-Chiozzi M, Danner S, et al. Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. Lancet1998;351:543–9.

5. Connors M, Kovacs JA, Krevat S, et al. HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nature Med1997;3:533–40.

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. On quantifying heterogeneous treatment effects with regression‐based individualized treatment rules: Loss function families and bounds on estimation error;Stat;2024-05-07

2. Predictors of CD4+ Count Changes in HIV-Infected Patients Receiving Antiretroviral Therapy;2022-12-06

3. Adherence to contemporary antiretroviral treatment regimens and impact on immunological and virologic outcomes in a US healthcare system;PLOS ONE;2022-02-14

4. Modelling trends of CD4 counts for patients on antiretroviral therapy (ART): a comprehensive health care clinic in Nairobi, Kenya;BMC Infectious Diseases;2022-01-04

5. Impact of pharmacist interventions on drug-related problems and laboratory markers in outpatients with human immunodeficiency virus infection;Therapeutics and Clinical Risk Management;2014-08